|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Unicycive Therapeutics, Inc. (UNCY) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
14,510,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Unicycive Therapeutics is a biotechnology company focused on developing treatments for certain medical conditions. Co.'s existing development programs are focused on the development of two therapies: Renazorb, for treatment of hyperphosphatemia in patients with chronic kidney disease (CKD); and UNI 494, for treatment of acute kidney injury (AKI). CKD is the gradual loss of kidney function that can get worse over time leading to lasting damage. AKI is a sudden episode of kidney failure or kidney damage (within the first 90 days of injury). After 90 days, the patient is considered to have progressed into CKD.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
15,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$12,375 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gupta Shalabh K. |
CEO |
• • – |
2023-07-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
104,612 |
2,527,449 |
|
- |
|
| Gupta Pramod |
EVP, Pharmaceuticals and BD |
• – – |
2023-07-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
41,845 |
41,845 |
|
- |
|
| Jermasek Douglas |
EVP of Corporate Strategy |
• – – |
2023-07-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
104,612 |
175,012 |
|
- |
|
| Aggarwal Gaurav |
Director |
– • – |
2023-07-11 |
4 |
A |
$0.00 |
$0 |
I/I |
3,470,152 |
3,470,152 |
|
- |
|
| Jermasek Douglas |
|
– – – |
2022-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
70,400 |
|
- |
|
| Schiller Brigitte |
Director |
– • – |
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,738 |
26,738 |
|
- |
|
| Schiller Brigitte |
Director |
– • – |
2022-05-16 |
4 |
B |
$0.83 |
$12,375 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
| Ryan John L |
Director |
– • – |
2021-07-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
58,140 |
|
- |
|
| Laumas Sandeep |
Director |
– • – |
2021-07-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
56,977 |
|
- |
|
| Laumas Sandeep |
Director |
– • – |
2021-07-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
48,838 |
|
- |
|
| Gupta Shalabh K. |
CEO & PresidentOfficer |
• • – |
2021-07-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,446,022 |
|
- |
|
| Gupta Shalabh K. |
CEO & PresidentOfficer |
• • – |
2021-07-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,321,092 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
